Less invasive surfactant administration and complications of preterm birth

Abstract In a large cohort study of the German Neonatal Network (GNN) we aimed to evaluate whether less invasive surfactant administration (LISA) strategy is associated with complications of preterm birth. Within the observational period n = 7533 very-low-birth-weight infants (VLBWI) with gestationa...

Full description

Bibliographic Details
Main Authors: Christoph Härtel, Pia Paul, Kathrin Hanke, Alexander Humberg, Angela Kribs, Katrin Mehler, Matthias Vochem, Christian Wieg, Claudia Roll, Egbert Herting, Wolfgang Göpel
Format: Article
Language:English
Published: Nature Portfolio 2018-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-26437-x
_version_ 1818998807644340224
author Christoph Härtel
Pia Paul
Kathrin Hanke
Alexander Humberg
Angela Kribs
Katrin Mehler
Matthias Vochem
Christian Wieg
Claudia Roll
Egbert Herting
Wolfgang Göpel
author_facet Christoph Härtel
Pia Paul
Kathrin Hanke
Alexander Humberg
Angela Kribs
Katrin Mehler
Matthias Vochem
Christian Wieg
Claudia Roll
Egbert Herting
Wolfgang Göpel
author_sort Christoph Härtel
collection DOAJ
description Abstract In a large cohort study of the German Neonatal Network (GNN) we aimed to evaluate whether less invasive surfactant administration (LISA) strategy is associated with complications of preterm birth. Within the observational period n = 7533 very-low-birth-weight infants (VLBWI) with gestational age 22 0/7 to 28 6/7 weeks were enrolled in GNN; n = 1214 VLBWI never received surfactant, n = 2624 VLBWI were treated according to LISA procedure, n = 3695 VLBWI had surfactant via endotracheal tube (ETT). LISA was associated with a reduced risk for adverse outcome measures including mortality [odds ratio (OR) 0.66 (95% CI: 0.51–0.84), p < 0.001] bronchopulmonary dysplasia [BPD; OR 0.55 (95% CI: 0.49–0.62), p < 0.001], intracerebral hemorrhage (ICH) grade II-IV [OR 0.55 (95% CI: 0.48–0.64), p < 0.001] and retinopathy of prematurity [ROP; OR 0.62 (95% CI: 0.45–0.85), p < 0.001]. Notably, LISA was associated with an increased risk for focal intestinal perforation [FIP; OR 1.49 (95% CI: 1.14–1.95), p = 0.002]. The differences in FIP rates were primarily observed in VLBWI born <26 weeks (LISA: 10.0 vs. ETT: 7.4%, p = 0.029). Our observational data confirm that LISA is associated with improved outcome. In infants <26 weeks we noted an increased risk for FIP. Future randomized controlled trials including LISA need to integrate safety analyses for this particular subgroup.
first_indexed 2024-12-20T22:07:24Z
format Article
id doaj.art-43ae25fa5b514f2ca99615232530b831
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-20T22:07:24Z
publishDate 2018-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-43ae25fa5b514f2ca99615232530b8312022-12-21T19:25:15ZengNature PortfolioScientific Reports2045-23222018-05-01811710.1038/s41598-018-26437-xLess invasive surfactant administration and complications of preterm birthChristoph Härtel0Pia Paul1Kathrin Hanke2Alexander Humberg3Angela Kribs4Katrin Mehler5Matthias Vochem6Christian Wieg7Claudia Roll8Egbert Herting9Wolfgang Göpel10Department of Pediatrics, University of LübeckDepartment of Pediatrics, University of LübeckDepartment of Pediatrics, University of LübeckDepartment of Pediatrics, University of LübeckDepartment of Neonatology, University of CologneDepartment of Neonatology, University of CologneDepartment of Neonatology, Olga Hospital StuttgartDepartment of Neonatology, Klinikum AschaffenburgDepartment of Neonatology, Vest Children’s Hospital Datteln, University Witten-HerdeckeDepartment of Pediatrics, University of LübeckDepartment of Pediatrics, University of LübeckAbstract In a large cohort study of the German Neonatal Network (GNN) we aimed to evaluate whether less invasive surfactant administration (LISA) strategy is associated with complications of preterm birth. Within the observational period n = 7533 very-low-birth-weight infants (VLBWI) with gestational age 22 0/7 to 28 6/7 weeks were enrolled in GNN; n = 1214 VLBWI never received surfactant, n = 2624 VLBWI were treated according to LISA procedure, n = 3695 VLBWI had surfactant via endotracheal tube (ETT). LISA was associated with a reduced risk for adverse outcome measures including mortality [odds ratio (OR) 0.66 (95% CI: 0.51–0.84), p < 0.001] bronchopulmonary dysplasia [BPD; OR 0.55 (95% CI: 0.49–0.62), p < 0.001], intracerebral hemorrhage (ICH) grade II-IV [OR 0.55 (95% CI: 0.48–0.64), p < 0.001] and retinopathy of prematurity [ROP; OR 0.62 (95% CI: 0.45–0.85), p < 0.001]. Notably, LISA was associated with an increased risk for focal intestinal perforation [FIP; OR 1.49 (95% CI: 1.14–1.95), p = 0.002]. The differences in FIP rates were primarily observed in VLBWI born <26 weeks (LISA: 10.0 vs. ETT: 7.4%, p = 0.029). Our observational data confirm that LISA is associated with improved outcome. In infants <26 weeks we noted an increased risk for FIP. Future randomized controlled trials including LISA need to integrate safety analyses for this particular subgroup.https://doi.org/10.1038/s41598-018-26437-x
spellingShingle Christoph Härtel
Pia Paul
Kathrin Hanke
Alexander Humberg
Angela Kribs
Katrin Mehler
Matthias Vochem
Christian Wieg
Claudia Roll
Egbert Herting
Wolfgang Göpel
Less invasive surfactant administration and complications of preterm birth
Scientific Reports
title Less invasive surfactant administration and complications of preterm birth
title_full Less invasive surfactant administration and complications of preterm birth
title_fullStr Less invasive surfactant administration and complications of preterm birth
title_full_unstemmed Less invasive surfactant administration and complications of preterm birth
title_short Less invasive surfactant administration and complications of preterm birth
title_sort less invasive surfactant administration and complications of preterm birth
url https://doi.org/10.1038/s41598-018-26437-x
work_keys_str_mv AT christophhartel lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT piapaul lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT kathrinhanke lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT alexanderhumberg lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT angelakribs lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT katrinmehler lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT matthiasvochem lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT christianwieg lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT claudiaroll lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT egbertherting lessinvasivesurfactantadministrationandcomplicationsofpretermbirth
AT wolfganggopel lessinvasivesurfactantadministrationandcomplicationsofpretermbirth